Business · 22/02/2024Updated: 10/17/2026 · 1 min read
FDA Releases Final Guidance on Assessing COVID-19 Symptoms in Clinical Trials
Summary
The FDA is releasing a final guidance to help sponsors and investigators measure and analyze COVID-19-related symptoms in clinical trials for COVID-19 prevention or treatment, even though the public health emergency has ended.